Home
INMB
INMB News

Latest INmune Bio Inc. Common stock (INMB) News on July 27, 2024

INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, August 1, 2024

GlobeNewswire

2 days ago

INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, August 1, 2024

INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer

GlobeNewswire

3 days ago

INmune Bio Inc. Publishes Novel Biology on Natural Killer Cancer Immunotherapy INKmune™ in the Journal for ImmunoTherapy of Cancer

Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

Simply Wall St.

15 days ago

Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

INmune Bio’s unique Alzheimer’s trial endpoint receives validation

Clinical Trials Arena

a month ago

INmune Bio’s unique Alzheimer’s trial endpoint receives validation

INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial

GlobeNewswire

a month ago

INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

2 months ago

INmune Bio to Join Russell 3000 Index in July

INmune Bio Inc. to Join Russell 3000® Index

GlobeNewswire

2 months ago

INmune Bio Inc. to Join Russell 3000® Index

INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript

Insider Monkey

2 months ago

INmune Bio, Inc. (NASDAQ:INMB) Q1 2024 Earnings Call Transcript

INmune Bio First Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 months ago

INmune Bio First Quarter 2024 Earnings: EPS Misses Expectations

INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update

GlobeNewswire

3 months ago

INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update

INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9

GlobeNewswire

3 months ago

INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9

INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years

GlobeNewswire

3 months ago

INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years

INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

3 months ago

INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

INmune Bio Independent Director Acquires 80% More Stock

Simply Wall St.

3 months ago

INmune Bio Independent Director Acquires 80% More Stock

INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

3 months ago

INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

GlobeNewswire

3 months ago

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering

GlobeNewswire

3 months ago

INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering

INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024

GlobeNewswire

4 months ago

INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript

INmune Bio Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

INmune Bio Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

INmune Bio Inc (INMB) Posts Year-End Earnings, Reveals Net Loss Amidst Clinical Advancements

GuruFocus.com

4 months ago

INmune Bio Inc (INMB) Posts Year-End Earnings, Reveals Net Loss Amidst Clinical Advancements

INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update

GlobeNewswire

4 months ago

INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update

INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28

GlobeNewswire

4 months ago

INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28

INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy

GlobeNewswire

4 months ago

INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy

INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™

GlobeNewswire

5 months ago

INmune Bio Reports Significant EEG Improvement in Alzheimer’s Patients Treated with XPro™

INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

5 months ago

INmune Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024

GlobeNewswire

6 months ago

INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024

Insiders own 24% of INmune Bio, Inc. (NASDAQ:INMB) shares but retail investors control 53% of the company

Simply Wall St.

6 months ago

Insiders own 24% of INmune Bio, Inc. (NASDAQ:INMB) shares but retail investors control 53% of the company

Clearfield (CLFD) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Clearfield (CLFD) Reports Q1 Loss, Tops Revenue Estimates

INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program

GlobeNewswire

6 months ago

INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program

12 Highest Rated Mattresses Under $1000

Insider Monkey

6 months ago

12 Highest Rated Mattresses Under $1000

Third Coast Bancshares, Inc. (TCBX) Q4 Earnings and Revenues Top Estimates

Zacks

6 months ago

Third Coast Bancshares, Inc. (TCBX) Q4 Earnings and Revenues Top Estimates

ATSG Announces New President of Airline Subsidiary ATI

Business Wire

6 months ago

ATSG Announces New President of Airline Subsidiary ATI

Capital Bancorp Inc (CBNK) Reports Steady Earnings Amid Market Volatility

GuruFocus.com

6 months ago

Capital Bancorp Inc (CBNK) Reports Steady Earnings Amid Market Volatility

Associated Press Finance

6 months ago

Capital Bancorp: Q4 Earnings Snapshot

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

Business Wire

6 months ago

Virtus Diversified Income & Convertible Fund Discloses Sources of Distribution – Section 19(a) Notice

WhiteHorse Finance, Inc. To Report Fourth Quarter 2023 and Full Year Financial Results

PR Newswire

6 months ago

WhiteHorse Finance, Inc. To Report Fourth Quarter 2023 and Full Year Financial Results

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

Business Wire

6 months ago

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

GDEV announces final results of previously announced self tender offer to purchase for cash a minimum of 15,000,000, up to 20,000,000 of its ordinary shares at a purchase price of $2.00 per ordinary share

GlobeNewswire

6 months ago

GDEV announces final results of previously announced self tender offer to purchase for cash a minimum of 15,000,000, up to 20,000,000 of its ordinary shares at a purchase price of $2.00 per ordinary share

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

GlobeNewswire

6 months ago

ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology

Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Business Wire

6 months ago

Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Insider Sell: Chief Scientific Officer Edward Feener Sells 22,679 Shares of KalVista ...

GuruFocus.com

6 months ago

Insider Sell: Chief Scientific Officer Edward Feener Sells 22,679 Shares of KalVista ...

Business Wire

7 months ago

First Trust Energy Income and Growth Fund Declares its Quarterly Distribution of $0.30 Per Share

MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions

Zacks

7 months ago

MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions

Euroseas Ltd. (ESEA) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks

7 months ago

Euroseas Ltd. (ESEA) Soars 6.3%: Is Further Upside Left in the Stock?

Getty Realty Corp. Provides 2023 Business Update

Business Wire

7 months ago

Getty Realty Corp. Provides 2023 Business Update

Amicus (FOLD) Issues Preliminary Revenue Results for FY23

Zacks

7 months ago

Amicus (FOLD) Issues Preliminary Revenue Results for FY23

Reuters

7 months ago

UPDATE 2-Allogene to cut 22% of its workforce

Reuters

7 months ago

Allogene to cut 22% of its workforce

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

GlobeNewswire

7 months ago

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

7 months ago

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer

AI, taxes, real estate, healthcare: Best of 2023 theme weeks

Yahoo Finance Video

7 months ago

AI, taxes, real estate, healthcare: Best of 2023 theme weeks

Unisys Wins Coveted "The Drum Award" in the B2B Rebrand or Relaunch Category

PR Newswire

7 months ago

Unisys Wins Coveted "The Drum Award" in the B2B Rebrand or Relaunch Category

XOMA Declares Quarterly Preferred Stock Dividends

GlobeNewswire

7 months ago

XOMA Declares Quarterly Preferred Stock Dividends

INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA

GlobeNewswire

7 months ago

INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA

Peapack-Gladstone Bank’s Boonton Charity Christmas Tree Sale Supports Sound Start Foundation

GlobeNewswire

7 months ago

Peapack-Gladstone Bank’s Boonton Charity Christmas Tree Sale Supports Sound Start Foundation

Unisys Revises Estimate of One-Time, Non-Cash, Pre-Tax Settlement Charge Related to Previously Announced Purchase of Group Annuity Contracts

PR Newswire

7 months ago

Unisys Revises Estimate of One-Time, Non-Cash, Pre-Tax Settlement Charge Related to Previously Announced Purchase of Group Annuity Contracts

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

GlobeNewswire

7 months ago

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

SoundThinking Expands into Latin America with Launch of ShotSpotter in Montevideo, Uruguay

GlobeNewswire

7 months ago

SoundThinking Expands into Latin America with Launch of ShotSpotter in Montevideo, Uruguay

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

GlobeNewswire

8 months ago

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

NeoGames’ Pariplay signs deal with Tipico US for further North American growth

GlobeNewswire

8 months ago

NeoGames’ Pariplay signs deal with Tipico US for further North American growth

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)

Simply Wall St.

8 months ago

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Liquidity Services Inc Earnings Call

Liquidity Services Inc (LQDT) Reports Growth in GMV and Revenue for Q4 Fiscal Year 2023

GuruFocus.com

8 months ago

Liquidity Services Inc (LQDT) Reports Growth in GMV and Revenue for Q4 Fiscal Year 2023

SoundThinking Sets Upcoming Financial Conference Schedule

GlobeNewswire

8 months ago

SoundThinking Sets Upcoming Financial Conference Schedule

Insider Sell Alert: CFO Sonia Jain Sells 39,191 Shares of Cars.com Inc

GuruFocus.com

8 months ago

Insider Sell Alert: CFO Sonia Jain Sells 39,191 Shares of Cars.com Inc

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

GlobeNewswire

8 months ago

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease

GlobeNewswire

8 months ago

INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease

McEwen Mining Announces Flow-Through Financing

GlobeNewswire

8 months ago

McEwen Mining Announces Flow-Through Financing

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Investor's Business Daily

8 months ago

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Thomson Reuters StreetEvents

8 months ago

Q3 2023 Y-mAbs Therapeutics Inc Earnings Call

Marinus Pharmaceuticals to Present at the 6th Annual Evercore ISI HealthCONx Conference

Business Wire

8 months ago

Marinus Pharmaceuticals to Present at the 6th Annual Evercore ISI HealthCONx Conference

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

8 months ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

GuruFocus.com

8 months ago

Y-mAbs Therapeutics Inc (YMAB) Reports Strong Revenue Growth Amidst Operational Streamlining

Brilliant Earth (BRLT) Q3 Earnings Beat Estimates, Decline Y/Y

Zacks

8 months ago

Brilliant Earth (BRLT) Q3 Earnings Beat Estimates, Decline Y/Y

GuruFocus.com

9 months ago

Microvast Holdings Inc Reports Substantial Year-Over-Year Growth in Q3 2023

Stellus Capital Investment Corporation (NYSE:SCM) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Stellus Capital Investment Corporation (NYSE:SCM) Q3 2023 Earnings Call Transcript

Arbutus to Present at Jefferies London Healthcare Conference

GlobeNewswire

9 months ago

Arbutus to Present at Jefferies London Healthcare Conference

GuruFocus.com

9 months ago

Nuvation Bio Inc (NUVB) Reports Q3 2023 Financial Results

Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

9 months ago

Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Share on Social Networks: